The Corporate Roundtable
The Corporate Roundtable (CRT) was created to establish a relationship between the AAN, AAN Foundation, and Industry. The CRT is an AAN Foundation-sponsored membership organization of companies that are committed to working together with the neurological community to meet the following AAN Foundation goals:
- Stimulate broad-based support to improve quality of care and quality of life for people with neurological disease
- Promote research and public education in the neurosciences
- Advance public understanding of disorders of the brain
2010 Corporate Roundtable Members
$40,000
Allergan, Inc.
Eli Lilly and Company
EMD Serono, Inc.
Forest Laboratories, Inc.
Genentech, Inc./Roche
Teva Neuroscience, Inc.
$30,000
Eisai Inc.
JANSSEN Alzheimer Immunotherapy
Pfizer Inc
Sepracor Inc.
UCB Inc.
$20,000
Acorda Therapeutics, Inc.
Bayer Healthcare Pharmaceuticals, Inc.
Biogen Idec
Boehringer Ingelheim Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc.
Genzyme Corporation
Medivation, Inc.
Merz Pharmaceuticals Inc.
Novartis Pharmaceuticals Corporation
PhotoThera, Inc.
Questcor Pharmaceuticals, Inc.
Upsher-Smith Laboratories, Inc.
- Current as of February 24, 2010
